Artificial intelligence is transforming how life sciences organizations approach drug development, diagnostics, personalized care and more.| AssistRx
AssistRx today announced it has completed an asset acquisition from AllazoHealth, a healthcare technology company driving therapy initiation, adherence and health outcomes with artificial intelligence (AI)-powered personalization.| AssistRx
As life sciences organizations increasingly adopt direct-to-consumer (DTC) models, evaluating the risks and exploring alternative approaches is crucial to best support patient and program needs.| AssistRx
Event will address critical issues and challenges confronting the commercial healthcare system. Orlando, Fla. – Nov. 12, 2024 – AssistRx, the advanced therapy initiation and patient solutions provider, today announced its participation as a Diamond Sponsor for Drug Channels Leadership Forum, to be hosted by the Drug Channels Institute (DCI), an HMP Global company, at ... The post AssistRx Joins Inaugural Drug Channels Leadership Forum as Diamond Sponsor appeared first on AssistRx.| AssistRx
Dispensing specialty-lite products through the retail channel can often limit life sciences organizations’ visibility into the patient journey. This pathway can also reduce opportunities to connect patients to support programs, as many specialty pharmacies are familiar with supporting these programs and processes while retail pharmacies are not. In this Drug Channels Institute article, Vice President ... The post Drug Channels — Innovative Models for Improving Access and Visibility for Sp...| AssistRx